NCT00760539View on ClinicalTrials.gov

Safety and Efficacy of Travoprost/Timolol BAC-free

PHASE3CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/Timolol 0.5% BAC-free ophthalmic solution

DRUG

Travoprost 0.004%/Timolol 0.5% ophthalmic solution

Trial Locations (1)

205-0001

Manabe Clinic, Hamura

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY